NDC codes

FDA NDC Directory
Product NDC (as listed)0378-6920Labeler and product segments. Claims need a package NDC.
Product NDC at billing width00378-6920Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
0378-6920-780037869207800378692078120 TABLET in 1 BOTTLE, PLASTIC (0378-6920-78)Marketed from Nov 21, 2018

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Abiraterone Acetate
Generic name (nonproprietary)
abiraterone acetate
Active ingredients
Abiraterone acetate — 250 mg/1
Dosage form
Tablet
Route
Oral
Labeler
Mylan Pharmaceuticals Inc.NDC labeler code 0378
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 208446
Marketing start
Listing expires
Other FDA classes
Cytochrome P450 17A1 Inhibitors (Mechanism)Cytochrome P450 2C8 Inhibitors (Mechanism)Cytochrome P450 2D6 Inhibitors (Mechanism)
Identifiers
Product ID 0378-6920_18e5ffff-c938-46e0-bf7a-1c1ab44e8a6dSPL ID 18e5ffff-c938-46e0-bf7a-1c1ab44e8a6dSPL set ID fe02db79-fa04-441f-b514-70bd74af6624RxCUI 1100075, 1918042UNII EM5OCB9YJ6
Pharmacologic class
Cytochrome P450 17A1 Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400378692078 followed by a unit qualifier and the quantity

Package 00378-6920-78. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

Abiraterone acetate tablets are indicated in combination with prednisone for the treatment of patients with • Metastatic castration-resistant prostate cancer (CRPC) • Metastatic high-risk castration-sensitive prostate cancer (CSPC) Abiraterone acetate tablets are a CYP17 inhibitor indicated in combination with prednisone for the treatment of patients with • metastatic castration-resistant prostate cancer (CRPC). ( 1 ) • metastatic high-risk castration-sensitive prostate cancer (CSPC). ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0378-6920

What is NDC 0378-6920?
0378-6920 is the product NDC for Abiraterone Acetate, Abiraterone acetate 250 mg/1 tablet, listed with the FDA by Mylan Pharmaceuticals Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Abiraterone Acetate.
What is the active ingredient?
Abiraterone acetate.
Who is the labeler?
Mylan Pharmaceuticals Inc., NDC labeler code 0378. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Abiraterone Acetate?
28 other product NDCs are listed under this name. See all Abiraterone Acetate NDCs.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Abiraterone Acetate NDCs
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)
Abiraterone AcetateAbiraterone acetate 250 mg/1TabletOralAvPAK50268-03250268-0032-12
Abiraterone AcetateAbiraterone acetate 250 mg/1TabletOralDr. Reddys Laboratories Inc75907-22475907-0224-04
Abiraterone AcetateabirateroneAbiraterone acetate 250 mg/1TabletOralAmerican Health Packaging60687-79060687-0790-21
Abiraterone AcetateAbiraterone acetate 500 mg/1TabletOralDr. Reddys Laboratories Inc43598-46843598-0468-3843598-0468-60
Abiraterone AcetateabirateroneAbiraterone acetate 250 mg/1TabletOralAmneal Pharmaceuticals LLC60219-116560219-1165-07
Abiraterone AcetateabirateroneAbiraterone acetate 500 mg/1TabletOralAmneal Pharmaceuticals LLC60219-175460219-1754-06
Abiraterone acetateAbiraterone acetate 500 mg/1Tablet, Film coatedOralFlorida Pharmaceutical Products, LLC71921-17771921-0177-06
abiraterone acetateAbiraterone acetate 250 mg/1TabletOralFlorida Pharmaceutical Products, LLC.71921-17871921-0178-20
abiraterone acetateAbiraterone acetate 500 mg/1TabletOralGlenmark Pharmaceuticals Inc., USA68462-88268462-0882-60
abiraterone acetateAbiraterone acetate 500 mg/1TabletOralNORTHSTAR RX LLC72603-11172603-0111-01

All 29 Abiraterone Acetate NDCs

Other NDCs under ANDA 208446

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 208446
ProductStrengthForm · routeLabelerProduct NDC
Abiraterone AcetateAbiraterone acetate 500 mg/1Tablet, Film coatedOralMylan Pharmaceuticals Inc.0378-6921
Abiraterone AcetateAbiraterone acetate 500 mg/1Tablet, Film coatedOralGolden State Medical Supply, Inc.51407-989
Abiraterone AcetateAbiraterone acetate 500 mg/1Tablet, Film coatedOralBryant Ranch Prepack72162-2151

Free account

Log in to keep searching

You’ve used your 3 free searches. Med-Code is free: log in or create a free profile to keep looking up NDCs, J-codes and drugs.

Create a free profileLog in